Medication info
Exrotan Tablets 5/80 mg

Exrotan Tablets 5/80 mg

Prescription medicationTabletOral
Ingredient · strength
Valsartan›80mg / 1 tabletAmlodipine Besylate›6.94mg / 1 tablet
Manufacturer / importer
Nexpam Korea Co., Ltd.
Appearance
Dark yellow round film-coated tablet
Packaging
28 tablets/box[((14 tablets/Alu-Alu)×2))]
Approval status
Active

MFDS item code 201603219 · Approved 2016.06.07 · Insurance code 662503480

Summary

Main use
Treatment of essential hypertension not controlled with monotherapy
Who takes it
Adults · Children
Adult dose
The recommended dose of this medicine is 1 tablet once daily, taken with water, with or without food. It is recommended that it be taken at the same time each day, if possible (e.g., in the morning). Before starting this medicine, it is recommended that the dose be adjusted using the individual components (amlodipine or valsartan). However, if blood pressure is not adequately controlled with monotherapy using the individual components, switching directly to this medicine may be considered as follows: ㆍ5/80 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or valsartan 80 mg monotherapy. ㆍ5/160 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or valsartan 160 mg monotherapy. ㆍ10/160 mg: For patients whose blood pressure is not adequately controlled with amlodipine 10 mg or valsartan 160 mg monotherapy, or with 5/160 mg. Patients currently taking valsartan and amlodipine concomitantly may switch to this medicine (a combination product containing the same amounts of each active ingredient) for convenience. Patients with renal impairment: No dose adjustment is required in patients with mild or moderate renal impairment (creatinine clearance 10mL/min or greater); however, this medicine should not be administered to patients with severe renal impairment (creatinine clearance less than 10mL/min) or patients on dialysis. In patients with moderate renal impairment, monitoring of potassium levels and creatinine is recommended. Patients with hepatic impairment: In patients with mild or moderate hepatic impairment, the daily dose of valsartan should not exceed 80mg. This medicine should not be administered to patients with severe hepatic impairment, biliary cirrhosis, biliary obstruction, or cholestasis. Elderly patients aged 65 years or older: Caution should be exercised when increasing the dose.
Child dose
This drug is not recommended for use in pediatric patients under 18 years of age because its safety and efficacy have not been established.

Ingredients

Manufacturer
Nexpam Korea Co., Ltd.

Efficacy & effects

Treatment of essential hypertension not controlled with monotherapy

  • Essential hypertension
View approved original text

This medication is used when blood pressure is not adequately controlled with amlodipine or valsartan monotherapy in the treatment of essential hypertension. The combination of the two components effectively lowers blood pressure, reduces cardiovascular burden, and helps prevent complications. It supports safe and effective blood pressure control in patients with hypertension.

How to take

Adult dose

The recommended dose of this medicine is 1 tablet once daily, taken with water, with or without food. It is recommended that it be taken at the same time each day, if possible (e.g., in the morning). Before starting this medicine, it is recommended that the dose be adjusted using the individual components (amlodipine or valsartan). However, if blood pressure is not adequately controlled with monotherapy using the individual components, switching directly to this medicine may be considered as follows: ㆍ5/80 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or valsartan 80 mg monotherapy. ㆍ5/160 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or valsartan 160 mg monotherapy. ㆍ10/160 mg: For patients whose blood pressure is not adequately controlled with amlodipine 10 mg or valsartan 160 mg monotherapy, or with 5/160 mg. Patients currently taking valsartan and amlodipine concomitantly may switch to this medicine (a combination product containing the same amounts of each active ingredient) for convenience. Patients with renal impairment: No dose adjustment is required in patients with mild or moderate renal impairment (creatinine clearance 10mL/min or greater); however, this medicine should not be administered to patients with severe renal impairment (creatinine clearance less than 10mL/min) or patients on dialysis. In patients with moderate renal impairment, monitoring of potassium levels and creatinine is recommended. Patients with hepatic impairment: In patients with mild or moderate hepatic impairment, the daily dose of valsartan should not exceed 80mg. This medicine should not be administered to patients with severe hepatic impairment, biliary cirrhosis, biliary obstruction, or cholestasis. Elderly patients aged 65 years or older: Caution should be exercised when increasing the dose.

Child dose

This drug is not recommended for use in pediatric patients under 18 years of age because its safety and efficacy have not been established.

Precautions

This medication can cause serious harm or death to the fetus and newborn if taken during the second and third trimesters of pregnancy; therefore, it should be discontinued immediately upon confirmation of pregnancy. Patients should not take this medication if they are allergic to the active ingredients or similar medications, are pregnant or breastfeeding, have severe kidney or liver dysfunction, or certain heart conditions. Patients with low sodium or fluid levels may experience hypotension, so it is important to check their condition before taking the medication, and to monitor blood pressure and status carefully during treatment. Patients with high potassium levels should be cautious when taking this medication with potassium supplements or other medications that increase potassium levels, and should frequently check their potassium concentration. Patients with kidney issues or kidney transplant recipients may need special attention due to possible changes in kidney function while using this medication. If signs of angioedema (swelling of the face, lips, tongue, throat) appear during treatment with this medication, it should be discontinued immediately and not taken again. Patients with heart failure or myocardial infarction may experience changes in kidney function and hypotension during treatment, necessitating regular kidney function tests. This medication may cause dizziness or fatigue while driving or operating machinery; therefore, caution is advised. In the case of an overdose, symptoms such as hypotension, dizziness, and increased heart rate may appear, and in severe instances, emergency treatment may be required. This medication may interact with other antihypertensives, potassium-sparing diuretics, NSAIDs, and some antibiotics, so patients should consult with their physician or pharmacist before using it in combination with other drugs. Breastfeeding women are not advised to take this medication, and use in children or adolescents under 18 years of age is not recommended due to insufficient evidence of safety and efficacy. Elderly patients may be prescribed the same dosage as adults, but caution is necessary according to individual conditions. It is recommended to undergo regular liver and kidney function tests during treatment with this medication, and to inform healthcare providers immediately if any abnormal symptoms occur.

Side effects

Nasopharyngitis, influenza, hypersensitivity, visual impairment, anxiety, headache, dizziness, drowsiness, positional dizziness, paresthesia, vertigo, tinnitus, tachycardia, palpitations, syncope, orthostatic hypotension, hypotension, cough, pharyngeal and laryngeal pain, diarrhea, nausea, abdominal pain, constipation, dry mouth, rash, erythema, hyperhidrosis, rash, itching, joint swelling, lumbago, arthritis, muscle spasms, lethargy, polyuria, nocturia, erectile dysfunction, edema, peripheral edema, facial swelling, peripheral edema, fatigue, flushing, weakness, facial flushing, decreased hemoglobin, decreased hematocrit, neutropenia, thrombocytopenia, hypersensitivity including serum sickness, increased serum potassium, vasculitis, elevated liver function tests, angioedema, myalgia, renal failure, kidney damage, increased serum creatinine, insomnia, reduced libido, pharyngitis, rhinitis, sinusitis, upper respiratory tract infection, viral infection, intestinal vascular edema, diplopia, thrombocytopenia, leukopenia, allergic reaction, hyperglycemia, insomnia, mood changes, tremors, sensory impairment, taste disturbance, peripheral neuropathy, hypertonia, arrhythmia, bradycardia, atrial fibrillation, ventricular tachycardia, myocardial infarction, vasculitis, dyspnea, rhinitis, vomiting, dyspepsia, pancreatitis, gastritis, gingival hyperplasia, hepatitis, jaundice, alopecia, purpura, skin depigmentation, photosensitivity reaction, angioedema, urticaria, erythema multiforme, Stevens-Johnson syndrome, myalgia, urinary disturbance, nocturnal enuresis, gynecomastia, pain, malaise, chest pain, weight loss, weight gain, increased liver enzymes, breast discomfort, abdominal discomfort, gastroesophageal reflux, neck pain, hypercholesterolemia, hypoglycemia, nervous excitability, Stevens-Johnson syndrome, arthralgia, skeletal pain, rhabdomyolysis, gingival hyperplasia

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly closed container to protect it from air and moisture, and it is best kept at room temperature between 1 and 30 degrees Celsius. By maintaining appropriate temperature and environment, the effectiveness and safety of the medication can be preserved for a long time.

Appearance and packaging

Appearance

Dark yellow round film-coated tablet

Package unit

28 tablets/box[((14 tablets/Alu-Alu)×2))]

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.